Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic \(\beta\)-Cells

DSpace/Manakin Repository

Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic \(\beta\)-Cells

Citable link to this page

 

 
Title: Cannabinoids Inhibit Insulin Receptor Signaling in Pancreatic \(\beta\)-Cells
Author: Doyle, Máire E.; Liu, Zhuo; Lao, Qizong; Shin, Yu-Kyong; Carlson, Olga D.; Thomas, Sam; Napora, Joshua K.; Moaddel, Ruin; Maudsley, Stuart; Martin, Bronwen; Egan, Josephine M.; Kim, Wookhyun; Kim, Hee Seung; Lee, Eun-Kyung; Wang, Yan; Kulkarni, Rohit Narayan

Note: Order does not necessarily reflect citation order of authors.

Citation: Kim, Wook, Máire E. Doyle, Zhuo Liu, Qizong Lao, Yu-Kyong Shin, Olga D. Carlson, Hee Seung Kim, et al. 2011. Cannabinoids inhibit insulin receptor signaling in pancreatic \(\beta\)-cells. Diabetes 60(4): 1198-1209.
Full Text & Related Files:
Abstract: Objective: Optimal glucose homeostasis requires exquisitely precise adaptation of the number of insulin-secreting \(\beta\)-cells in the islets of Langerhans. Insulin itself positively regulates \(\beta\)-cell proliferation in an autocrine manner through the insulin receptor (IR) signaling pathway. It is now coming to light that cannabinoid 1 receptor (CB1R) agonism/antagonism influences insulin action in insulin-sensitive tissues. However, the cells on which the CB1Rs are expressed and their function in islets have not been firmly established. We undertook the current study to investigate if intraislet endogenous cannabinoids (ECs) regulate \(\beta\)-cell proliferation and if they influence insulin action. Research Design and Methods: We measured EC production in isolated human and mouse islets and \(\beta\)-cell line in response to glucose and KCl. We evaluated human and mouse islets, several \(\beta\)-cell lines, and CB1R-null (CB1R\(^{−/−}\)) mice for the presence of a fully functioning EC system. We investigated if ECs influence \(\beta\)-cell physiology through regulating insulin action and demonstrated the therapeutic potential of manipulation of the EC system in diabetic (db/db) mice. Results: ECs are generated within \(\beta\)-cells, which also express CB1Rs that are fully functioning when activated by ligands. Genetic and pharmacologic blockade of CB1R results in enhanced IR signaling through the insulin receptor substrate 2-AKT pathway in \(\beta\)-cells and leads to increased \(\beta\)-cell proliferation and mass. CB1R antagonism in db/db mice results in reduced blood glucose and increased \(\beta\)-cell proliferation and mass, coupled with enhanced IR signaling in \(\beta\)-cells. Furthermore, CB1R activation impedes insulin-stimulated IR autophosphorylation on \(\beta\)-cells in a G\(\alpha_i\)-dependent manner. Conclusions: These findings provide direct evidence for a functional interaction between CB1R and IR signaling involved in the regulation of \(\beta\)-cell proliferation and will serve as a basis for developing new therapeutic interventions to enhance \(\beta\)-cell function and proliferation in diabetes.
Published Version: doi:10.2337/db10-1550
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064093/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10336925
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters